NIVF 📈 NewGenIvf Group Limited - Overview
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Common Stock •
NIVF: Fertility, Reproductive, Genetic, Testing, Solutions
Additional Sources for NIVF Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NIVF Stock Overview
| Market Cap in USD | 7m |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 2024-04-03 |
NIVF Stock Ratings
| Growth 5y | -70.3% |
| Fundamental | -30.7% |
| Dividend | - |
| Rel. Strength Industry | -1804 |
| Analysts | - |
| Fair Price Momentum | 0.29 USD |
| Fair Price DCF | - |
NIVF Dividends
No Dividends PaidNIVF Growth Ratios
| Growth Correlation 3m | -68.4% |
| Growth Correlation 12m | -77.1% |
| Growth Correlation 5y | -77.1% |
| CAGR 5y | -96.34% |
| CAGR/Mean DD 5y | -1.08 |
| Sharpe Ratio 12m | -0.24 |
| Alpha | -194.37 |
| Beta | 4.35 |
| Volatility | 525.61% |
| Current Volume | 2706.5k |
| Average Volume 20d | 6377.3k |
What is the price of NIVF stocks?
As of December 22, 2024, the stock is trading at USD 0.33 with a total of 2,706,500 shares traded.
Over the past week, the price has changed by +5.05%, over one month by -44.03%, over three months by -48.53% and over the past year by -96.34%.
As of December 22, 2024, the stock is trading at USD 0.33 with a total of 2,706,500 shares traded.
Over the past week, the price has changed by +5.05%, over one month by -44.03%, over three months by -48.53% and over the past year by -96.34%.
Is NewGenIvf Group Limited a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, NewGenIvf Group Limited (NASDAQ:NIVF) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -30.66 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NIVF as of December 2024 is 0.29. This means that NIVF is currently overvalued and has a potential downside of -12.12%.
Probably not. Based on ValueRay Fundamental Analyses, NewGenIvf Group Limited (NASDAQ:NIVF) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -30.66 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NIVF as of December 2024 is 0.29. This means that NIVF is currently overvalued and has a potential downside of -12.12%.
Is NIVF a buy, sell or hold?
NewGenIvf Group Limited has no consensus analysts rating.
NewGenIvf Group Limited has no consensus analysts rating.
What are the forecast for NIVF stock price target?
According to ValueRays Forecast Model, NIVF NewGenIvf Group Limited will be worth about 0.4 in December 2025. The stock is currently trading at 0.33. This means that the stock has a potential upside of +6.06%.
According to ValueRays Forecast Model, NIVF NewGenIvf Group Limited will be worth about 0.4 in December 2025. The stock is currently trading at 0.33. This means that the stock has a potential upside of +6.06%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.4 | 6.1% |